Efficacy and Safety of Ulotaront in the Treatment of Schizophrenia: Results of Two 6-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials

John Kane, Heather Dworak,Kenneth Koblan, Armin Szegedi,Robert Goldman,Yan Li, Alison Fitzgerald,Antony Loebel,Stephen Marder

NEUROPSYCHOPHARMACOLOGY(2023)

引用 0|浏览2
暂无评分
关键词
Schizophrenia (SCZ),TAAR1,Phase III Trial,Clinical Trial,Ulotaront
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要